Anti-TNF-a Strategies in CHF:
Data from Randomized, Controlled Clinical Trials

Arthritis Advisory Committee

March 4, 2003
Ellis F. Unger, M.D.
Office of Therapeutics Research and Review (OTRR)
Center for Biologics Evaluation and Research (CBER)
U.S. Food and Drug Administration (US FDA)